NotesFAQContact Us
Search Tips
Back to results
Peer reviewed Peer reviewed
Direct linkDirect link
ERIC Number: EJ739737
Record Type: Journal
Publication Date: 2006-May
Pages: 29
Abstractor: Author
Reference Count: 0
ISSN: ISSN-0033-5630
Kairos as Indeterminate Risk Management: The Pharmaceutical Industry's Response to Bioterrorism
Scott, J. Blake
Quarterly Journal of Speech, v92 n2 p115-143 May 2006
The pharmaceutical industry's response to the threat of bioterrorism following 9-11 invoked the rhetorical notion of kairos as an urgent and ongoing opportunity not only to protect the nation but also to improve the industry's reputation and fortify its political power. Yet the notion of kairos as seizing an advantage--grounded in modernist assumptions about agency and control--is also complicated by the case history of big pharma's response, which left the industry vulnerable to heightened and additional risks. This case history suggests that kairos can be less about seizing an advantage than about indeterminately responding to shifting, unbounded, uncertain, unpredictable, and uncontrollable risks shaped by the processes of globalization. (Contains 112 notes.)
Routledge. 270 Madison Avenue, New York, NY 10016. Tel: 212-216-7800; Fax: 212-244-1563; Web site:
Publication Type: Journal Articles; Reports - Descriptive
Education Level: N/A
Audience: N/A
Language: English
Sponsor: N/A
Authoring Institution: N/A